Bibliome.ai browser hg19
Search
About
Stats
FAQ
EGFR c.52C>A ;(p.L18I)
Variant ID: 7-55087022-C-A
NM_005228.3(
EGFR
):c.52C>A;(p.L18I)
This variant was identified in 9 publications
View GRCh38 version.
Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP
Publications:
PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy.
Molecular Cancer
Kelm, Jeremy M JM; Pandey, Deepti S DS; Malin, Evan E; Kansou, Hussein H; Arora, Sahil S; Kumar, Raj R; Gavande, Navnath S NS
Publication Date: 2023-03-30
Variant appearance in text: EGFR: L18I
PubMed Link:
36991452
Variant Present in the following documents:
Main text
12943_2022_Article_1707.pdf
View BVdb publication page
E3 ligase ligand optimization of Clinical PROTACs.
Frontiers In Chemistry
Jiang, Hanrui H; Xiong, Huan H; Gu, Shuang-Xi SX; Wang, Mingliang M
Publication Date: 2023
Variant appearance in text: EGFR: L18I
PubMed Link:
36733714
Variant Present in the following documents:
Main text
fchem-11-1098331.pdf
View BVdb publication page
Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future.
Molecules (Basel, Switzerland)
Li, Rui R; Liu, Miao M; Yang, Zhenya Z; Li, Jiao J; Gao, Yuxin Y; Tan, Ruirong R
Publication Date: 2022-12-12
Variant appearance in text: EGFR: L18I
PubMed Link:
36557960
Variant Present in the following documents:
Main text
molecules-27-08828.pdf
View BVdb publication page
The Role of BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia: A Clinical View.
Journal Of Experimental Pharmacology
Tambaro, Francesco Paolo FP; De Novellis, Danilo D; Wierda, William G WG
Publication Date: 2021
Variant appearance in text: EGFR: L18I
PubMed Link:
34744463
Variant Present in the following documents:
Main text
jep-13-923.pdf
View BVdb publication page
The resistance mechanisms and treatment strategies of BTK inhibitors in B-cell lymphoma.
Hematological Oncology
Wang, Haoran H; Zhang, Wentao W; Yang, Jingyi J; Zhou, Keshu K
Publication Date: 2021-12
Variant appearance in text: EGFR: L18I
PubMed Link:
34651869
Variant Present in the following documents:
Main text
View BVdb publication page
Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins.
Theranostics
Lin, Jiayi J; Jin, Jinmei J; Shen, Yiwen Y; Zhang, Lijun L; Gong, Gang G; Bian, Huiting H; Chen, Hongzhuan H; Nagle, Dale G DG; Wu, Ye Y; Zhang, Weidong W; Luan, Xin X
Publication Date: 2021
Variant appearance in text: EGFR: L18I
PubMed Link:
34373745
Variant Present in the following documents:
Main text
View BVdb publication page
Opportunities and Challenges of Small Molecule Induced Targeted Protein Degradation.
Frontiers In Cell And Developmental Biology
He, Ming M; Lv, Wenxing W; Rao, Yu Y
Publication Date: 2021
Variant appearance in text: EGFR: L18I
PubMed Link:
34249939
Variant Present in the following documents:
Main text
View BVdb publication page
Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell lymphomas.
Cancers
George, Bhawana B; Chowdhury, Sayan Mullick SM; Hart, Amber A; Sircar, Anuvrat A; Singh, Satish Kumar SK; Nath, Uttam Kumar UK; Mamgain, Mukesh M; Singhal, Naveen Kumar NK; Sehgal, Lalit L; Jain, Neeraj N
Publication Date: 2020-05-22
Variant appearance in text: EGFR: L18I
PubMed Link:
32455989
Variant Present in the following documents:
Main text
View BVdb publication page
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.
Nature Communications
Kis, Olena O; Kaedbey, Rayan R; Chow, Signy S; Danesh, Arnavaz A; Dowar, Mark M; Li, Tiantian T; Li, Zhihua Z; Liu, Jessica J; Mansour, Mark M; Masih-Khan, Esther E; Zhang, Tong T; Bratman, Scott V SV; Oza, Amit M AM; Kamel-Reid, Suzanne S; Trudel, Suzanne S; Pugh, Trevor J TJ
Publication Date: 2017-05-11
Variant appearance in text: ERBB: 52C>A
PubMed Link:
28492226
Variant Present in the following documents:
ncomms15086-s3.xlsx, sheet 1
View BVdb publication page